Abstract:Human lysozyme (hLYZ), known for its bacteriolytic activity, is widely applied in the food and pharmaceutical industries as an antimicrobial agent. However, its extensive application was limited by its low large-scale production efficiency. In this study, a combinational method of integrating codon optimization, multiple gene copies, and ER molecular chaperone co-expression was developed to improve the heterologous production of hLYZ in Pichia pastoris GS115. Our results showed that increasing the copy number of the optimized hLYZ gene in P. pastoris could enhance its secretory production level up to 1.57-fold. The recombinant opt-hLYZ-6C strain that contains six copies of opt-hLYZ gene exhibited the highest mRNA transcription levels, giving the highest production of 0.22 ± 0.02 mg/mL of hLYZ in the medium supernatant with a bacteriolytic activity of 14,680 ± 300 U/mL against Micrococcus lysodeikticus in the shaking flask experiment. Moreover, co-overexpression of ER retention molecular chaperones, such as Pdi1 or Ero1, in the recombinant opt-hLYZ-6C strain both presented positive effects on the secretory production of hLYZ. Our further characterization indicated that tandem co-expression of Ero1 and Pdi1 together presented an added-up effect. The secretory production of hLYZ in the medium supernatant reached 0.34 ± 0.02 mg/mL of the recombinant opt-hLYZ-6C-EP strain in the shaking flask experiment, with a bacteriolytic activity of 21,200 ± 400 U/mL. Compared to the recombinant opt-hLYZ-1C strain, these final improvements were calculated as 2.43-fold and 2.30-fold on secretory protein levels and antibacterial activity, respectively. Finally, the recombinant opt-hLYZ-6C-EP strain was applied for high-density cultivation in 5 L of fermenter, in which the secretory yield of hLYZ reached 2.34 ± 0.02 mg/mL in the medium supernatant, with a bacteriolytic activity of 1.76 ± 0.02 × 105 U/mL against M. lysodeikticus. All these numbers presented the highest heterologous production levels of hLYZ in microbial systems.

A Study on the Expression of Recombinant Human Lysozyme in Pichia Pastoris

A Combinational Strategy for Effective Heterologous Production of Functional Human Lysozyme in Pichia pastoris

High-yield production of the human lysozyme by Pichia pastoris SMD1168 using response surface methodology and high-cell-density fermentation

Secreted Expression of Bovine Lysozyme-1 in Pichia Pastoris.

Constitutive Expression of Human Goose-type Lysozyme 2 in Pichia Pastoris Using the GAP Promoter

Optimization of Conditions to Stabilize and Maximize Pichia Pastoris Fermentation of Human Lysozyme - Tachyplesin Ⅰ Fusion Protein

Fermentation of recombinant human lysozyme in Pichia pastoris

The molecular modification, expression, and the antibacterial effects studies of human lysozyme

Production of LYZL6, a Novel Human C-Type Lysozyme, in Recombinant Pichia Pastoris Employing High Cell Density Fed-Batch Fermentation.

Secreted Expression of Human Lysozyme in the Yeast Pichia Pastoris under the Direction of the Signal Peptide from Human Serum Albumin

Efficient Production of Human Goose-Type Lysozyme 2 in the Methylotrophic Yeast Pichia Pastoris.

Expression and anti-bacterial activity of site-directed human lysozyme mu-tant in Pichia pasteris

High Level Expression and Purification of Recombinant Human Serum Albumin in Pichia Pastoris.

High Level Expression of Rhizomucor miehei Lipase Gene in Pichia pastoris

Heterologous Expression of a Synthetic Gene Encoding Lignin Peroxidase H2 in Pichia Pastoris

Engineering Pichia pastoris for Efficient Production of a Novel Bifunctional Strongylocentrotus purpuratus Invertebrate-Type Lysozyme

Expression of Human GLP-1-IgG Fc Fusion Protein in Pichia Pastoris

Expression of Soluble Recombinant Transglutaminase from Zea Mays in Pichia Pastoris

Induction and expression of T4 lysozyme gene in Pichia pastoris

Expression of Recombinant Human Interleukin-13 in Pichia Pastoris and Its Bioactivity in Vitro

Sequence Analysis and High-Efficiency Expression in Pichia pastoris